BRAHMS KRYPTOR CgA II
Device
Brahms GmbH
Total Payments
$322,979
Transactions
28
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $10,200 | 1 | 0 |
| 2019 | $312,779 | 27 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $322,979 | 28 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Chromogranin A as Surveillance biomarker in Patients with cARcinoids - the CASPAR study | Brahms GmbH | $322,979 | 0 |
Top Doctors Receiving Payments for BRAHMS KRYPTOR CgA II
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Palo Alto, CA | $322,979 | 28 |
Ad
Manufacturing Companies
- Brahms GmbH $322,979
Product Information
- Type Device
- Total Payments $322,979
- Total Doctors 0
- Transactions 28
About BRAHMS KRYPTOR CgA II
BRAHMS KRYPTOR CgA II is a device associated with $322,979 in payments to 0 healthcare providers, recorded across 28 transactions in the CMS Open Payments database. The primary manufacturer is Brahms GmbH.
Payment data is available from 2019 to 2020. In 2020, $10,200 was paid across 1 transactions to 0 doctors.
The most common payment nature for BRAHMS KRYPTOR CgA II is "Unspecified" ($322,979, 100.0% of total).
BRAHMS KRYPTOR CgA II is associated with 1 research study, including "Chromogranin A as Surveillance biomarker in Patients with cARcinoids - the CASPAR study" ($322,979).